Perdoceo Education: Despite Attractive Valuation, Regulatory Risks Can’t Be Overlooked

Michael Burrell/iStock via Getty Images Investment thesis: Perdoceo Education (NASDAQ:PRDO) sports an attractive valuation at just 8.4x forward P/E versus the sector median of 15.4x and has posted solid financial performance including expanding operating margins and a healthy balance sheet. However, the for-profit education industry faces intensifying scrutiny under the Biden administration over issues like…

Read More

PayPal: 4 Overlooked But Impactful Growth Drivers In 2024 (NASDAQ:PYPL)

Erikona Investment Thesis There have been numerous articles published on Seeking Alpha analyzing PayPal (NASDAQ:PYPL). Most discussions appropriately touched on PYPL’s share buyback program, their collaboration with KKR to sell buy-now-pay-later (BNPL) debt, the sale of Happy Returns, the new management team, opportunities with Braintree’s unbranded checkout solutions, and PYPL’s leadership position globally. While these…

Read More

Taro Pharmaceutical Industries Stock Is An Overlooked Opportunity (NYSE:TARO)

Shidlovski/iStock via Getty Images Hidden Treasure Taro Pharmaceutical Industries Ltd. (NYSE:TARO) is a lightly traded, Israel-based pharmaceutical firm. Taro specializes in researching and developing healthcare products and sells ingredients to other pharma companies. We believe Taro stock deserves a Buy assessment after considering its risks/rewards. Seeking Alpha’s Quant Rating is a Strong Buy with top…

Read More

CFNAI: The Most Important And Overlooked Economic Number

da-kuk The Chicago Fed National Activity Index (CFNAI) is arguably one of the most important and overlooked economic indicators. Each month, economists, the media, and investors pour over various mainstream economic indicators, from GDP to employment and inflation, to determine what markets will likely do next. While economic numbers like GDP or the monthly non-farm…

Read More

Chemed (CHE): Still Bullish On Economic Characteristics, But Risks Shouldn’t Be Overlooked

naphtalina/iStock via Getty Images Investment briefing The equity stock of Chemed Corporation (NYSE:CHE) has rolled over since its impressive run in FY’22—’23 and there are now several updates to discuss. Chief among these are the company’s latest numbers for Q2 FY’23, and a detailed appraisal of its economic characteristics. In my last publication, I outlined…

Read More

Scotiabank: Overlooked Risks Discussed (NYSE:BNS)

JHVEPhoto Today’s article about The Bank of Nova Scotia (BNS), more commonly known as Scotiabank, outlines a few overlooked risk factors. Although a valuation model is embedded in the article, the analysis aims to add to market transparency by discussing micro factors instead of conducting a holistic analysis of The Bank of Nova Scotia’s stock….

Read More